New PET tracer aims to sharpen prostate cancer detection
NCT ID NCT05324332
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares a new radioactive tracer, 68Ga-P16-093, with the standard tracer 68Ga-PSMA-11 for PET/CT imaging in 50 men with untreated prostate cancer. The goal is to see which tracer better detects tumors and their spread. Participants will receive both tracers within a week, and the number of tumors detected will be compared.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
68Ga-P16-093 and 68Ga-PSMA-11 (radioactive tracers for PET imaging)
What this could lead to
If successful, this could lead to a more accurate imaging method for detecting prostate cancer and its spread.
What could go wrong
This is a small, early pilot study with only 50 participants. The new tracer may not prove better than the existing one, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••